ZA911279B - Novel protein compositions - Google Patents

Novel protein compositions

Info

Publication number
ZA911279B
ZA911279B ZA911279A ZA911279A ZA911279B ZA 911279 B ZA911279 B ZA 911279B ZA 911279 A ZA911279 A ZA 911279A ZA 911279 A ZA911279 A ZA 911279A ZA 911279 B ZA911279 B ZA 911279B
Authority
ZA
South Africa
Prior art keywords
novel protein
protein compositions
compositions
novel
protein
Prior art date
Application number
ZA911279A
Other languages
English (en)
Inventor
Jorgen Frederik Hansen
Frederik Hansen Jorgen
Ulla Ribel-Madsen
Ribel-Madsen Ulla
Original Assignee
Novo Nordisk As
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Novo Nordisk As filed Critical Novo Nordisk As
Publication of ZA911279B publication Critical patent/ZA911279B/xx

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • A61K38/16Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22Hormones
    • A61K38/28Insulins
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/52Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an inorganic compound, e.g. an inorganic ion that is complexed with the active ingredient
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/08Drugs for disorders of the metabolism for glucose homeostasis

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Diabetes (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Endocrinology (AREA)
  • Epidemiology (AREA)
  • Obesity (AREA)
  • General Chemical & Material Sciences (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Emergency Medicine (AREA)
  • Zoology (AREA)
  • Hematology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Inorganic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Medicinal Preparation (AREA)
  • Chairs For Special Purposes, Such As Reclining Chairs (AREA)
ZA911279A 1990-02-21 1991-02-21 Novel protein compositions ZA911279B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DK045590A DK45590D0 (OSRAM) 1990-02-21 1990-02-21

Publications (1)

Publication Number Publication Date
ZA911279B true ZA911279B (en) 1991-10-30

Family

ID=8093754

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA911279A ZA911279B (en) 1990-02-21 1991-02-21 Novel protein compositions

Country Status (12)

Country Link
EP (1) EP0516704B1 (OSRAM)
JP (1) JPH05503940A (OSRAM)
AU (1) AU641991B2 (OSRAM)
CA (1) CA2075982A1 (OSRAM)
DE (1) DE69100626D1 (OSRAM)
DK (1) DK45590D0 (OSRAM)
HU (1) HUT63858A (OSRAM)
IE (1) IE910579A1 (OSRAM)
NZ (1) NZ237176A (OSRAM)
PT (1) PT96841A (OSRAM)
WO (1) WO1991012817A1 (OSRAM)
ZA (1) ZA911279B (OSRAM)

Families Citing this family (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9316895D0 (en) * 1993-08-13 1993-09-29 Guy S And St Thomas Hospitals Hepatoselective insulin analogues
US6342225B1 (en) 1993-08-13 2002-01-29 Deutshces Wollforschungsinstitut Pharmaceutical active conjugates
US6011007A (en) * 1993-09-17 2000-01-04 Novo Nordisk A/S Acylated insulin
US6869930B1 (en) 1993-09-17 2005-03-22 Novo Nordisk A/S Acylated insulin
EP1132404A3 (en) * 1993-09-17 2002-03-27 Novo Nordisk A/S Acylated insulin
US6251856B1 (en) 1995-03-17 2001-06-26 Novo Nordisk A/S Insulin derivatives
US6451762B1 (en) 1997-10-24 2002-09-17 Novo Nordisk A/S Aggregates of human insulin derivatives
EP2107069B1 (en) 2003-08-05 2013-01-16 Novo Nordisk A/S Novel insulin derivatives
ES2402592T3 (es) 2003-08-05 2013-05-07 Novo Nordisk A/S Nuevos derivados de insulina
US8067362B2 (en) 2005-02-02 2011-11-29 Novo Nordisk As Insulin derivatives
PT1969004E (pt) 2005-12-28 2011-11-25 Novo Nordisk As Composições que compreendem uma insulina acilada e zinco e método para criar tais composições
JP5550338B2 (ja) 2006-07-31 2014-07-16 ノボ・ノルデイスク・エー/エス ペグ化持続型インスリン
ES2601839T3 (es) 2006-09-22 2017-02-16 Novo Nordisk A/S Análogos de insulina resistentes a proteasas
JP5496082B2 (ja) 2007-04-30 2014-05-21 ノボ・ノルデイスク・エー/エス タンパク質組成物を乾燥させる方法、乾燥タンパク質組成物、及び乾燥タンパク質を含有する薬学的組成物
JP5552046B2 (ja) 2007-06-13 2014-07-16 ノボ・ノルデイスク・エー/エス インスリン誘導体を含有する薬学的製剤
JP5762001B2 (ja) 2008-03-14 2015-08-12 ノボ・ノルデイスク・エー/エス プロテアーゼ安定化インスリンアナログ
EP2910571B1 (en) 2008-03-18 2016-10-05 Novo Nordisk A/S Protease stabilized, acylated insulin analogues
KR20110085985A (ko) 2008-10-30 2011-07-27 노보 노르디스크 에이/에스 하루 한번 주사 빈도보다 적은 인슐린 주사를 사용한 진성 당뇨병의 치료
JP6049625B2 (ja) 2010-10-27 2016-12-21 ノヴォ ノルディスク アー/エス 様々な注射間隔を用いて施されるインスリン注射を使用する、真性糖尿病の治療
JP6199956B2 (ja) 2012-04-11 2017-09-20 ノヴォ ノルディスク アー/エス インスリン製剤
WO2014177623A1 (en) 2013-04-30 2014-11-06 Novo Nordisk A/S Novel administration regime
WO2015052088A1 (en) 2013-10-07 2015-04-16 Novo Nordisk A/S Novel derivative of an insulin analogue
PE20210857A1 (es) 2016-12-16 2021-05-18 Novo Nordisk As Composiciones farmaceuticas que contienen insulina
US10335464B1 (en) 2018-06-26 2019-07-02 Novo Nordisk A/S Device for titrating basal insulin
EP3996679B1 (en) 2019-07-12 2023-09-06 Novo Nordisk A/S High concentration insulin formulation

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE971500C (de) * 1950-11-22 1959-02-05 Organon Nv Verfahren zur Herstellung von Insulin-Suspensionen mit verlaengerter Wirkung
DE1107374B (de) * 1958-01-31 1961-05-25 Organon Nv Verfahren zur Herstellung eines Insulin-Praeparates

Also Published As

Publication number Publication date
IE910579A1 (en) 1991-08-28
DK45590D0 (OSRAM) 1990-02-21
AU641991B2 (en) 1993-10-07
JPH05503940A (ja) 1993-06-24
CA2075982A1 (en) 1991-08-22
AU7337891A (en) 1991-09-18
DE69100626D1 (de) 1993-12-16
PT96841A (pt) 1991-11-29
HUT63858A (en) 1993-10-28
HU9202721D0 (en) 1992-12-28
NZ237176A (en) 1991-12-23
EP0516704A1 (en) 1992-12-09
WO1991012817A1 (en) 1991-09-05
EP0516704B1 (en) 1993-11-10

Similar Documents

Publication Publication Date Title
ZA911279B (en) Novel protein compositions
GB9005856D0 (en) Compositions
GB8901837D0 (en) Novel compositions
GB9021546D0 (en) Novel composition
GB9005440D0 (en) Composition
GB9007074D0 (en) Novel compositions
GB8906913D0 (en) Novel compositions
EP0445659A3 (en) Hair-set composition
GB9015822D0 (en) Compositions
GB9006537D0 (en) Composition
GB9113588D0 (en) Compositions
GB9008433D0 (en) Novel compositions
GB9027728D0 (en) Novel protein
GB9024924D0 (en) Novel compositions
EP0452632A3 (en) Dichloro-pentafluoropropanes-containing compositions
GB9004832D0 (en) Compositions
HU208481B (en) Mouth-hygienicd compositions
GB9007073D0 (en) Novel compositions
GB9008434D0 (en) Novel compositions
GB9021143D0 (en) Novel compositions
GB9021142D0 (en) Novel compositions
GB9019119D0 (en) Novel compositions
GB9008436D0 (en) Novel compositions
GB9008435D0 (en) Novel compositions
GB9021195D0 (en) Novel compositions